Drugs Health Pharma

GSK’s vaccine for severe RSV shows 43.3% effectiveness in third year

GSK Plc.’s single dose respiratory syncytial virus (RSV) vaccine for a severe form of the disease proved 43.3% effective in the third season.

Read More
Drugs Health Pharma

Sage Therapeutics halts trials of experimental drug to treat dementia

Sage Therapeutics Inc.’s experimental drug failed to meet its main goal of treating mild dementia due to Alzheimer's disease and the US, Cambridge-headquartered.

Read More
Climate Health Pharma

Global glaciers suffer largest mass loss in 50 yrs, 2023 driest for rivers

Glaciers suffered the largest mass loss in 50 years as last year marked the driest for global rivers in 33 years, according to.

Read More
Climate Health Medical

Human life expectancy has hit its upper limits, says US research

HQ Team October 8, 2024:Humanity is hitting the upper limit of life expectancy, according to a new study. Medical advances have led to.

Read More
Drugs Health Medical

J&J stops trials on drug to treat muscle-invasive bladder cancer

Johnson and Johnson discontinued a study of an investigational drug to treat bladder cancer after it failed to yield desired results

Read More
Drugs Health Medical

Balancing gut bacteria can reduce inflammation in rheumatoid arthritis

HQ Team October 7, 2024: Rheumatoid arthritis (RA), an autoimmune disease that causes joint and bone inflammation, is affected by gut bacteria. Researchers.

Read More
Drugs Health Medical

UK’s DIOSynVax develops single candidate vaccine for bird flu virus

UK-based DIOSynVax, a biotechnology company, has developed a single candidate vaccine neutralizing immune responses across the spectrum of very diverse H5 subtypes of influenza.

Read More
Drugs Health Pharma

US drug regulator clears Qnovia’s nicotine inhaler for clinical testing

HQ Team October 7, 2024: The US Food and Drug Administration (FDA)has cleared Qnovia Inc’s nicotine inhaler RespiRx for clinical trial. The US.

Read More
Drugs Health Medical

AstraZeneca in $1.92 million deal with HK-listed CSPC Pharmaceutical

British-Swedish AstraZeneca signed a $1.92 billion licensing agreement with CSPC Pharmaceutical Group to develop, manufacture and commercialize a compound to treat a metabolic.

Read More
Climate Health Medical

Vegetation cover in Antarctic Peninsula increases 10-fold in last four yrs: Study

Extreme warming in the Antarctic Peninsula has increased the vegetation cover in the region by more than tenfold over the last four decades,.

Read More